Abstract
An induced pluripotent stem cell line derived from a patient with neonatal diabetes and Fanconi-Bickel syndrome caused by a homozygous mutation in the SLC2A2 gene
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have